Inogen Acquires Breathe Oxygen Services

SANTA BARBARA, Calif., Sept. 1, 2011 /PRNewswire/ -- Inogen, Inc., a leading oxygen therapy services provider, has successfully completed the acquisition of Breathe Oxygen Services (BOS), a homecare respiratory services company located outside of Nashville, TN. Inogen currently services thousands of oxygen therapy patients across the country and looks forward to providing the same outstanding service and support to BOS patients.

The acquisition also enables Inogen to accept and service additional oxygen therapy patients throughout the state of Tennessee. "We welcome the patients of Breathe Oxygen Services to the Inogen family and now are pleased to offer Inogen's innovative products and services to all oxygen therapy patients in the state of Tennessee," says Raymond Huggenberger, Inogen CEO.

Inogen, a nationally accredited homecare provider by the Accreditation Commission for Health Care (ACHC), provides innovative products and services to increase freedom and independence for oxygen therapy patients. One such innovation is the company's Inogen One medical oxygen concentrator, a single solution for oxygen therapy at home, away, and for travel. For long term oxygen therapy patients in Tennessee, the Inogen One could bring a new perspective to their therapy that eliminates the worry of running out of oxygen in traditional portable tanks.

For more information on the Inogen One portable oxygen concentrator, please visit www.inogenone.com.

Full press release available here: http://www.inogenone.com/Inogen-Acquires-Breathe-Oxygen-Services/

Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes.

Corporate website: www.inogen.net
Product website: www.inogenone.com

SOURCE Inogen

Back to news